KB-2796, A New Ca2+Antagonist
- 1 June 1990
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 8 (2) , 105-116
- https://doi.org/10.1111/j.1527-3466.1990.tb00433.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effects of a New Calcium Channel Blocker, KB‐2796, on Protein Synthesis of the CA1 Pyramidal Cell and Delayed Neuronal Death Following Transient Forebrain IschemiaJournal of Neurochemistry, 1989
- Antiinflammatory effect of mace, aril of Myristica fragrans Houtt., and its active principles.The Japanese Journal of Pharmacology, 1989
- Effects of KB-2796, a New Calcium Antagonist, and Other Diphenylpiperazines on [3H]Nitrendipine BindingThe Japanese Journal of Pharmacology, 1988
- Benzylpiperazine derivatives. IV. Syntheses and cerebral vasodilating activities of 1-benzyl-4-diphenylmethylpiperazine derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1987
- Inhibition by KB-2796, a new Ca2+ entry blocker, of the contractile response of isolated dog cerebral and peripheral arteries.Folia Pharmacologica Japonica, 1987
- Monitoring of dopamine metabolism by in vivo voltammetry and high performance liquid chromatography in L-DOPA-treated rats.The Japanese Journal of Pharmacology, 1987
- A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction.Stroke, 1986
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986
- Cerebral circulation and metabolismJournal of Neurosurgery, 1984
- Cell Damage in the Brain: A Speculative SynthesisJournal of Cerebral Blood Flow & Metabolism, 1981